Effect of early weight loss on type 2 diabetes mellitus after 2 years of gastric banding

Postgraduate Medicine

Volumn 124, Issue 6, 2012, Pages 73-81

  Edelman, Steven ^a   Bhoyrul, Sunil ^b   Billy, Helmuth ^c   Cornell, Christopher ^c   Okerson, Ted ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS MEMORIAL HOSPITAL   (United States)

^c Ventura Advanced Surgical Associates   (United States)

^d ALLERGAN INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Laparoscopic adjustable gastric banding; Obesity; Type 2 diabetes mellitus; Weight loss

Indexed keywords

ANTIDIABETIC AGENT;

ADULT; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES CONTROL; DISEASE DURATION; DISEASE SEVERITY; EXPLANT; FEMALE; GASTRIC BAND; GASTRIC BANDING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; REMISSION; REOPERATION; TREATMENT RESPONSE; WEIGHT REDUCTION; ADOLESCENT; AGED; CLINICAL TRIAL; GASTROPLASTY; MIDDLE AGED; MULTICENTER STUDY; OBESITY;

ADOLESCENT; ADULT; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GASTROPLASTY; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OBESITY; REMISSION INDUCTION; WEIGHT LOSS; YOUNG ADULT;

MLCS; MLOWN;

EID: 84875771736     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2012.11.2590     Document Type: Article

References (36)

1. U.K. prospective diabetes study 16. Overview of six years' therapy of type II diabetes: a progressive disease. UK Prospective Diabetes Study Group. Diabetes. 1995;44(11):1249-1258.
2. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003;46(1):3-19.
3. Holman RR. Assessing the potential for alpha-glucosidase inhibitors in prediabetic states. Diabetes Res Clin Pract. 1998;40(suppl): S21-S25.
4. Centers for Disease Control and Prevention. Diabetes: successes and opportunities for population-based prevention and control: at a glance 2011. Atlanta, GA; Centers for Disease Control and Prevention. http:// www.cdc.gov/chronicdisease/resources/publications/AAG/ddt.htm. Accessed April 24, 2012.
5. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. NIH publication no. 98 4083, 1998. Bethesda, MD: National Heart, Lung, and Blood Institute. http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. Accessed April 24, 2012.
6. Bariatric surgical and procedural interventions in the treatment of obese patients with type 2 diabetes: a position statement from the International Diabetes Federation task force on epidemiology and prevention (2011). http://www.idf.org/webdata/docs/IDF-Position-Statement-Bariatric-Surgery.pdf. Accessed April 24, 2012.
7. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care. 1994;17(9):961-969.
8. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995; 122(7):481-486.
9. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894:1-253.
10. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007;132(6):2087-2102.
11. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303(3): 235-241.
12. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring). 2008; 16(10):2323-2330.
13. Nathan DM, Buse JB, Davidson MB, et al; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193-203.
14. Rodbard HW, Jellinger PS, Davidson JA, et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control. Endo Pract. 2009;15(suppl 6): 540-559.
15. O'Brien PE. Bariatric surgery: mechanisms, indications and outcomes. J Gastroenterol Hepatol. 2010;25(8):1358-1365.
16. Shukla AP, Ahn SM, Patel RT, Rosenbaum MW, Rubino F. Surgical treatment of type 2 diabetes: the surgeon perspective. Endocrine. 2011;40(2):151-161.
17. Buchanan TA. Stemming the tide of type 2 diabetes: bring on the "big guns". Obesity. 2010;18(6):1065-1067.
18. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248-256.
19. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323.
20. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567-1576.
21. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012; 366(17):1577-1585.
22. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Endo Pract. 2008; 14(suppl 1):1-83.
23. Shayani V, Voellinger D, Liu C, Cornell C, Okerson T. Safety and efficacy of the LAP-BAND AP® adjustable gastric band in the treatment of obesity: results at 2 years. Postgrad Med. 2012;124(4): 181-188.
24. LAP BAND AP® system device label. Santa Barbara, CA: Allergan, Inc. http://www.allergan.com/assets/pdf/lapband_dfu.pdf. Accessed May 8, 2012.
25. DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6(3):249-253.
26. Camastra S, Gastaldelli A, Mari A, et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia. 2011;54(8):2093-2102.
27. Pinkney J. The surgical panacea for diabetes: time for diabetologists to discriminate facts from fiction and flights of fantasy. Practical Diabetes Int. 2011;28(2):76-80.
28. Hamza N, Abbas MH, Darwish A, Shafeek Z, New J, Ammori BJ. Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass. Surg Obes Relat Dis. 2011;7(6): 691-696.
29. Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(3):254-259.
30. Handelsman Y, Mechanick JI, Blonde L, et al. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17(suppl 2):1-53.
31. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724-1737.
32. Sultan S, Gupta D, Parikh M, et al. Five-year outcomes of patients with type 2 diabetes who underwent laparoscopic adjustable gastric banding. Surg Obes Relat Dis. 2010;6(4):373-376.
33. Pontiroli AE, Folli F, Paganelli M, et al. Laparoscopic gastric banding prevents type 2 diabetes and arterial hypertension and induces their remission in morbid obesity: a 4-year case-controlled study. Diabetes Care. 2005;28(11):2703-2709.
34. Ponce J, Haynes B, Paynter S, et al. Effect of lap-band-induced weight loss on type 2 diabetes mellitus and hypertension. Obes Surg. 2004;14(10):1335-1342.
35. Wajchenberg BL. Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 2007;28(2):187-218.
36. Carelli AM, Youn HA, Kurian MS, Ren CJ, Fielding GA. Safety of the laparoscopic adjustable gastric band: 7 year data from a U.S. center of excellence. Surg Endosc. 2010;24(8):1819-1823.